Jeremy A. Duffy is a partner at Duffy & Shanley, one of the largest independently -owned marketing communications firms in New England. He leads marketing and business development efforts and has assisted in the agency's growth in national consumer brands by adding Fortune 500 companies and market segment leaders to the firm's roster.

Dr. Babak Alizadeh is Co-founder, COO and member of the board of directors at PrognosDx Health Inc., an epigenetic company addressing the need for personalized medicine solutions in the treatment of cancer.  A cancer biologist and entrepreneur, he has been involved with some of the most significant areas of the biotech industry at their inception, including genomics, stem cells, RNA interference, and epigenetics.  He has held a wide range of management positions in R&D, operations, business development and corporate venture fund management.

Patrick became the president of the National Association of Independent Schools (NAIS) in August 2001. NAIS is a voluntary membership organization for more than 1,200 independent (private) schools and associations of schools in the U.S. and abroad.

Charles Kane brings more than 20 years of senior executive-level experience including chief financial officer positions at RSA Security (now a part of EMC Corporation), Aspen Technology and Informix Software (now a part of IBM) as well as the role of president and CEO at Corechange. He is currently a member of the board of directors at Demandware – an ecommerce platform for some of the world’s largest retailers –and an Adjunct Professor of International Finance at MIT Sloan School of Management.

Susan Fonseca-Klein is an attorney and anthropologist. She is a Founding Architect of Singularity University and is the Creator of Women@TheFrontier. In 2008, Susan helped develop and launch SU, organizing the Founding Meeting (Sept 2008), structuring SU’s public launch at TED 2009, negotiating a successful 5-year partnership with NASA, and producing SU’s inaugural Graduate Studies Program and first Executive Program.

Dr. James Martin provided both the vision and support required to establish the Oxford Martin School, founded as the James Martin 21st Century School in 2005. He remains keenly engaged with the School's ambitions, and in March 2009 launched a new fundraising campaign for the School with a pledge of $50 million in matched funding.

Brock Reeve, a graduate of Yale and the Harvard Business School, is Executive Director of the Harvard Stem Cell Institute. In partnership with the Faculty Directors, he has overall responsibility for the operations and strategy of the institute whose mission is to use stem cells, both as tools and as therapies, to understand and treat the root causes of leading degenerative diseases.

David Skok joined Matrix Partners as a General Partner in May 2001. He has a wealth of experience running companies. David started his first company in 1977 at age 22. Since then David has founded a total of four separate companies and performed one turn-around. Three of these companies went public.
Read more.